IDEAS home Printed from https://ideas.repec.org/a/nat/natcom/v7y2016i1d10.1038_ncomms11551.html
   My bibliography  Save this article

ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation

Author

Listed:
  • Petrus R. de Jong

    (University of California, San Diego
    Sanford Burnham Prebys Medical Discovery Institute, NCI-Designated Cancer Center)

  • Koji Taniguchi

    (Laboratory of Gene Regulation and Signal Transduction, University of California, San Diego
    Graduate School of Medical Sciences, Kyushu University
    Keio University School of Medicine)

  • Alexandra R. Harris

    (University of California, San Diego
    Present address: Department of Pathology, University of Virginia School of Medicine, Charlottesville, Virginia 22908, USA)

  • Samuel Bertin

    (University of California, San Diego)

  • Naoki Takahashi

    (University of California, San Diego
    Niigata University Graduate School of Medical and Dental Sciences)

  • Jen Duong

    (University of California, San Diego)

  • Alejandro D. Campos

    (Sanford Burnham Prebys Medical Discovery Institute, NCI-Designated Cancer Center)

  • Garth Powis

    (Sanford Burnham Prebys Medical Discovery Institute, NCI-Designated Cancer Center)

  • Maripat Corr

    (University of California, San Diego)

  • Michael Karin

    (Laboratory of Gene Regulation and Signal Transduction, University of California, San Diego)

  • Eyal Raz

    (University of California, San Diego)

Abstract

The ERK1/2 MAPK signalling module integrates extracellular cues that induce proliferation and differentiation of epithelial lineages, and is an established oncogenic driver, particularly in the intestine. However, the interrelation of the ERK1/2 module relative to other signalling pathways in intestinal epithelial cells and colorectal cancer (CRC) is unclear. Here we show that loss of Erk1/2 in intestinal epithelial cells results in defects in nutrient absorption, epithelial cell migration and secretory cell differentiation. However, intestinal epithelial cell proliferation is not impeded, implying compensatory mechanisms. Genetic deletion of Erk1/2 or pharmacological targeting of MEK1/2 results in supraphysiological activity of the ERK5 pathway. Furthermore, targeting both pathways causes a more effective suppression of cell proliferation in murine intestinal organoids and human CRC lines. These results suggest that ERK5 provides a common bypass route in intestinal epithelial cells, which rescues cell proliferation upon abrogation of ERK1/2 signalling, with therapeutic implications in CRC.

Suggested Citation

  • Petrus R. de Jong & Koji Taniguchi & Alexandra R. Harris & Samuel Bertin & Naoki Takahashi & Jen Duong & Alejandro D. Campos & Garth Powis & Maripat Corr & Michael Karin & Eyal Raz, 2016. "ERK5 signalling rescues intestinal epithelial turnover and tumour cell proliferation upon ERK1/2 abrogation," Nature Communications, Nature, vol. 7(1), pages 1-15, September.
  • Handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11551
    DOI: 10.1038/ncomms11551
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/ncomms11551
    File Function: Abstract
    Download Restriction: no

    File URL: https://libkey.io/10.1038/ncomms11551?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:7:y:2016:i:1:d:10.1038_ncomms11551. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.